GR
Grifols
GRFS·NASDAQBarcelona ESFounded 194023,000 employees
Mid CapbiotechPublicHematology
Platform: Plasma
Market Cap
$6B
All Drugs
4
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (GRFS)
Loading GRFS stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GRF-8977 | GRF-8977 | Phase 1 | 1 | FcRn | Heart FailureACC | ||
| Teraosocimab | GRF-1684 | Phase 3 | 1 | GPRC5D | Fabry | ||
| Motacapivasertib | GRF-3378 | NDA/BLA | 2 | MDM2 | RCCEpilepsy | ||
| GRF-4589 | GRF-4589 | Phase 2 | 1 | SHP2 | GISTDMD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)